Hydrogels Based on 2-Hydroxyethylmethacrylate and Chitosan: Preparation, Swelling Behavior, and Drug Delivery
Source abstract
Abstract
The authors report preparation of chitosan by deacetylation of chitin extracted from shrimp shells. The quality of chitosan depended on the chemical extraction process, the concentration of chemicals used, soaking time, sequence of deproteination, decalcification, and deacetylation. Hydrogels composed of hydroxyethylmethacrylate and chitosan were subsequently prepared and their swelling and ibuprofen delivery kinetics at various chitosan concentrations were studied. The swelling properties of the network varied with the chitosan concentration. Furthermore, the swelling process followed second-order kinetics, while ibuprofen diffusion into the hydrogel showed Fickian behavior.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Materials and Mechanics · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Richards A. G. · 1951
2. Hanafi M. · Kimia. Terapan. Indonesia · 2000 · 10 · 17
3. Djaeni M. · 2002
4. 10.1016/j.jconrel.2007.01.00410.1016/j.jconrel.2007.01.004 ↗
5. 10.1002/macp.1985.02186081510.1002/macp.1985.021860815 ↗
6. 10.1163/15685620432300527110.1163/156856204323005271 ↗
7. 10.1016/S0169-409X(01)00240-X10.1016/S0169-409X(01)00240-X ↗
8. Junginger H. · Pharmazeutische Industrie · 1991 · 53 · 1056
9. 10.1016/j.addr.2006.09.00410.1016/j.addr.2006.09.004 ↗
10. Mekawati F. E. · Jurnal Matematika dan Sains · 2000 · 8 · 51
11. 10.1016/S0939-6411(00)00090-410.1016/S0939-6411(00)00090-4 ↗
12. 10.1002/(SICI)1097-0126(200004)49:4<337::AID-PI375>3.0.CO;2-B10.1002/(SICI)1097-0126(200004)49:4<337::AID-PI375>3.0.CO;2-B ↗
13. Yang X. · 1998
14. 10.1016/0009-2509(91)80177-Z10.1016/0009-2509(91)80177-Z ↗
15. Firestone B. · Polym. Commun. · 1988 · 29 · 204
16. 10.1163/138577209X1248689662341810.1163/138577209X12486896623418 ↗
17. 10.1080/00914037.2013.76916110.1080/00914037.2013.769161 ↗
18. 10.1080/03602559.2013.76336010.1080/03602559.2013.763360 ↗
19. 10.1021/ma00189a02110.1021/ma00189a021 ↗
20. 10.1016/j.eurpolymj.2006.01.01010.1016/j.eurpolymj.2006.01.010 ↗
21. 10.1016/S0169-409X(01)00243-510.1016/S0169-409X(01)00243-5 ↗
22. 10.1016/S0169-409X(01)00241-110.1016/S0169-409X(01)00241-1 ↗
23. 10.1016/j.carbpol.2005.03.00910.1016/j.carbpol.2005.03.009 ↗
24. 10.1615/CritRevTherDrugCarrierSyst.v24.i2.2010.1615/CritRevTherDrugCarrierSyst.v24.i2.20 ↗
25. 10.1002/jbm.a.3066810.1002/jbm.a.30668 ↗
26. Bersch P. · J. Mater. Sci.: Mater. Med. · 1995 · 6 · 231
27. Sharma S. · Die Pharmazie · 2006 · 61 · 495
28. 10.1016/S0169-409X(01)00197-110.1016/S0169-409X(01)00197-1 ↗
29. 10.3166/acsm.32.431-44610.3166/acsm.32.431-446 ↗
30. Knapczyk J. · 1989
31. 10.1016/0378-5173(92)90353-410.1016/0378-5173(92)90353-4 ↗
32. 10.1007/s00253-008-1471-910.1007/s00253-008-1471-9 ↗
33. Kannan K. P. · World J. Sci. Technol. · 2011 · 1
34. 10.1016/S0144-8617(02)00300-410.1016/S0144-8617(02)00300-4 ↗
35. 10.1016/j.actbio.2011.10.00510.1016/j.actbio.2011.10.005 ↗
36. 10.1021/la300013710.1021/la3000137 ↗
37. 10.1002/1616-3028(200102)11:1<37::AID-ADFM37>3.0.CO;2-V10.1002/1616-3028(200102)11:1<37::AID-ADFM37>3.0.CO;2-V ↗
38. 10.1002/(SICI)1097-4628(19990705)73:1<113::AID-APP13>3.0.CO;2-D10.1002/(SICI)1097-4628(19990705)73:1<113::AID-APP13>3.0.CO;2-D ↗
39. Katime I. A. · 2004
40. 10.1002/macp.1990.02191051410.1002/macp.1990.021910514 ↗